bromodeoxyuridine has been researched along with naphthoquinones in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boothman, DA; Greer, S; Pardee, AB | 1 |
| Pedicelli, G | 1 |
| Narahara, H; Nasu, K; Nishida, M; Takai, N; Ueda, T; Yuge, A | 1 |
1 review(s) available for bromodeoxyuridine and naphthoquinones
| Article | Year |
|---|---|
[CHEMICAL RADIOSENSITIZATION].
Topics: Antifibrinolytic Agents; Bromodeoxyuridine; Dactinomycin; DNA; DNA, Neoplasm; Ethylmaleimide; Hyperbaric Oxygenation; Naphthoquinones; Neoplasms; Retinoids; Vitamin K | 1964 |
3 other study(ies) available for bromodeoxyuridine and naphthoquinones
| Article | Year |
|---|---|
Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
Topics: Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; DNA Repair; Drug Synergism; Humans; Laryngeal Neoplasms; Naphthoquinones; Radiation-Sensitizing Agents | 1987 |
[Radiosensitizing chemical agents. Radiobiological reasons and prospects for their use].
Topics: Acetates; Animals; Bromodeoxyuridine; Bromouracil; Carcinoma, Ehrlich Tumor; Cell Membrane; Cosmic Radiation; DNA; Fluorouracil; Iodine; Mice; Naphthoquinones; Pyrimidines; Radiation Effects; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1972 |
Beta-hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Survival; DNA Fragmentation; Endometriosis; Female; G1 Phase; G2 Phase; Humans; In Vitro Techniques; Naphthoquinones; Premenopause; Resting Phase, Cell Cycle; S Phase; Stromal Cells | 2006 |